Replimune
REPL
#4939
Rank
HK$14.17 B
Marketcap
HK$149.48
Share price
-0.83%
Change (1 day)
108.78%
Change (1 year)

Market capitalization of Replimune (REPL)

Market cap: HK$14.17 Billion

As of November 2026 Replimune has a market cap of HK$14.17 Billion. This makes Replimune the world's 4939th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Replimune from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$14.17 B133.11%
2025HK$6.07 B-17.01%
2024HK$7.32 B88.37%
2023HK$3.88 B-63.22%
2022HK$10.57 B6.67%
2021HK$9.90 B-27.1%
2020HK$13.59 B231.91%
2019HK$4.09 B65.29%
2018HK$2.47 B

End of Day market cap according to different sources

On Nov 21st, 2026 the market cap of Replimune was reported to be:

HK$14.17 Billion
by Nasdaq info icon info icon
HK$14.17 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
HK$5.99 B-57.69%๐Ÿ‡บ๐Ÿ‡ธ USA